about
Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitroThe absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice.Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitmentNeutrophils are required for both the sensitization and elicitation phase of contact hypersensitivityDifferential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo.Neutrophils in animal models of autoimmune diseaseThe role of neutrophils in autoimmune diseases.Feedback Amplification of Neutrophil Function.Dasatinib inhibits proinflammatory functions of mature human neutrophilsThe Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa AcquisitaCorrection: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro.Rac GTPase Activating Protein ARHGAP25 Regulates Leukocyte Transendothelial Migration in Mice.Lineage-Specific Analysis of Syk Function in Autoantibody-Induced Arthritis.Myeloid-Specific Deletion of Mcl-1 Yields Severely Neutropenic Mice That Survive and Breed in Homozygous FormImportance of Fc Receptor γ-Chain ITAM Tyrosines in Neutrophil Activation and Autoimmune ArthritisTyrosine Kinases in Autoimmune and Inflammatory Skin DiseasesNeutrophils as emerging therapeutic targets
P50
Q28546317-3B76B199-8735-4051-99DC-C5C210CBDDC6Q30540124-5CB467B0-B807-43BF-91FD-F8BD1C8479D5Q33432035-6C6E43EB-E4EA-4E40-940C-F246AC33AD8EQ34230548-83953278-F6FD-41E4-A89A-5BC5267BB663Q34924724-79FE3E12-D12F-4A03-B228-663360980FD2Q35061170-BD1D2ACE-D703-4473-90ED-6C1F06710C5DQ36768670-DE1DA778-F59A-410B-9B1A-197D0578C051Q36902110-FE10CEC6-6250-4F27-ACE6-68270846A989Q37985351-B687FDD4-DF95-4E65-B6F1-583CC9DA1DA0Q38829081-0DEA3E1B-5C41-4596-A184-F9F87D4750DCQ41885572-57430067-3235-4044-AA85-A283F11F68BEQ41929292-D999E1CE-C280-4E24-9CD5-9180C3B14578Q43126198-15249C4F-07DD-4EAB-98BC-3D807501BDEFQ48092085-073A6B01-425F-4385-B85C-E9F53CB44CD1Q54117883-B89A541D-EF43-4AF2-BAAF-A8D230E107EFQ59813706-742D23AA-327C-4C67-BCCD-C6B3502C0557Q64104748-9B39607C-1321-42A7-914A-9557BBCE5B1EQ92857827-636B7D72-5C57-45AD-B148-7A986B0E638EQ92861017-31415F80-41B2-40B8-8746-435CD2512644
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tamás Németh
@ast
Tamás Németh
@en
Tamás Németh
@es
Tamás Németh
@sl
type
label
Tamás Németh
@ast
Tamás Németh
@en
Tamás Németh
@es
Tamás Németh
@sl
prefLabel
Tamás Németh
@ast
Tamás Németh
@en
Tamás Németh
@es
Tamás Németh
@sl
P106
P21
P31
P496
0000-0001-6854-4301